The study is designed to evaluate the efficacy of etanercept 50 mg subcutaneously (SQ) weekly
plus tacrolimus 0.1% topical ointment twice daily compared to etanercept 50 mg SQ weekly plus
placebo ointment twice daily.
Phase:
Phase 2
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey